In collaboration with HealthChoice Illinois, Illinicare Health is expanding to a new service area effective April 1, 2018.

Please use the 2018 member ID card when processing claims for Marsh & McLennan members.

Effective April 1, 2018 Xtampza ER (oxycodone ER) will replace OxyContin as the preferred long-acting, abuse-deterrent oxycodone product.

CVS Caremark® Medicare Part D Services may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorization, quantity limits and/or step therapy restrictions on a drug and/or move a drug to a higher cost-sharing tier, we will notify you of the changes at least sixty (60) days before the date the change becomes effective.

OptumRx will be performing scheduled maintenance to the Claim Processing System beginning: